340 related articles for article (PubMed ID: 28166057)
21. Impact of interfractional motion on hypofractionated pencil beam scanning proton therapy and VMAT delivery for prostate cancer.
Moteabbed M; Trofimov A; Khan FH; Wang Y; Sharp GC; Zietman AL; Efstathiou JA; Lu HM
Med Phys; 2018 Jul; ():. PubMed ID: 30007067
[TBL] [Abstract][Full Text] [Related]
22. Statistical assessment of proton treatment plans under setup and range uncertainties.
Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
[TBL] [Abstract][Full Text] [Related]
23. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
24. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments.
den Otter LA; Kaza E; Kierkels RGJ; Meijers A; Ubbels FJF; Leach MO; Collins DJ; Langendijk JA; Knopf AC
Med Phys; 2018 Dec; 45(12):5525-5534. PubMed ID: 30229930
[TBL] [Abstract][Full Text] [Related]
25. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
[TBL] [Abstract][Full Text] [Related]
26. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
27. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
30. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
31. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
32. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
[TBL] [Abstract][Full Text] [Related]
33. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
34. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
35. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
36. Plan-library supported automated replanning for online-adaptive intensity-modulated proton therapy of cervical cancer.
Jagt TZ; Breedveld S; van Haveren R; Nout RA; Astreinidou E; Heijmen BJM; Hoogeman MS
Acta Oncol; 2019 Oct; 58(10):1440-1445. PubMed ID: 31271076
[No Abstract] [Full Text] [Related]
37. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique.
Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667
[TBL] [Abstract][Full Text] [Related]
38. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motion.
Wang Y; Efstathiou JA; Lu HM; Sharp GC; Trofimov A
Med Phys; 2013 Jul; 40(7):071714. PubMed ID: 23822418
[TBL] [Abstract][Full Text] [Related]
40. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
